Dermatology · Jersey City, NJ
NPI
1518674621
Since 2022
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
100 Town Square Pl Ste 409
Jersey City, NJ, 07310
Phone (201) 626-4040
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
183 services
Medicare patients, 2024
65
Average age 71
Drug cost, 2024
$1.6M
6,323 prescriptions
Company payments, 2025
$3,199
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey Tuazon was code 99213 (office e&m - established), 90 times for 55 patients. In total Jeffrey Tuazon billed 183 services in 11 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 90 | 55 | $66.80 | $6,012 |
| 11901 Skin | Office | 20 | 11 | $51.37 | $1,027 |
| 17004 Destruction Skin Lesion | Office | 19 | 13 | $127.28 | $2,418 |
| 99203 Office E&M - New | Office | 16 | 16 | $82.77 | $1,324 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey Tuazon prescribed most often to Medicare patients was Ketoconazole, with 796 prescriptions and refills. In total Jeffrey Tuazon wrote 6,323 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 796 | 811 | 278 | $17K |
| Metronidazole Generic | 409 | 412 | 146 | $31K |
| Tacrolimus Generic | 345 | 384 | 185 | $78K |
| Clobetasol Propionate Generic | 282 | 296 | 173 | $17K |
| Ammonium Lactate Generic | 273 | 281 | 123 | $5,956 |
| Selenium Sulfide Generic | 267 | 273 | 91 | $2,601 |
| Fluticasone Propionate Generic | 230 | 235 | 161 | $8,456 |
| Pimecrolimus Generic | 230 | 260 | 89 | $62K |
| Fluocinolone Acetonide Generic | 222 | 223 | 92 | $11K |
| Mupirocin Generic | 216 | 216 | 174 | $1,703 |
| Gentamicin Sulfate Generic | 176 | 177 | 138 | $7,534 |
| Clindamycin Phosphate Generic | 158 | 162 | 72 | $7,173 |
| Opzelura Ruxolitinib Phosphate | 156 | 159 | 43 | $304K |
| Mometasone Furoate Generic | 154 | 155 | 92 | $3,172 |
| Nystatin Generic | 152 | 155 | 66 | $4,442 |
Brand drugs: - claims; generic drugs: 5,609 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey Tuazon $3,199 ($3,199 in general payments such as food, travel and fees) from 17 companies. The largest payer was Incyte Corporation with $544.
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation INCY | 24 | $544 |
| Organon LLC OGN | 16 | $315 |
| Galderma Laboratories, L.P. GALD.SW | 13 | $305 |
| Pfizer Inc. PFE | 25 | $283 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $250 |
| LEO Pharma Inc. | 18 | $246 |
| Abbvie Inc. ABBV | 16 | $212 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $176 |
| Genzyme Corporation SNY | 12 | $149 |
| Arcutis Biotherapeutics, Inc. ARQT | 11 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.